Similar articles

Abstract: Primary age-related tauopathy (PART) is characterized by the presence of tau neurofibrillary tangles (NFTs) which are typically observed in alzheimer’;s disease (AD) brains, with few or without β-amyloid (Aβ) plaques. The diagnosis of PART can be categorized into “definite” or “possible” depending on the amount of Aβ plaques. Definite PART is diagnosed when NFTs are observed and the Braak stage is ≤IV, with Thal Aβ Phase 0 (Crary et al., 2014). According to the neuropathological diagnostic criteria, we reported that PART was frequently observed in the Chinese population according to our findings from specimens in our brain bank, with 47% of brain bank subjects meeting the criteria for PART. There is no consensus on the nature of PART. It remains to be elucidated whether PART is an early form of AD or a novel tauopathy (Duyckaerts et al., 2015; Jellinger et al., 2015).

原发性衰老相关性tau病在中国人群中的临床病理学研究

[1]Alafuzoff I, Ince PG, Arzberger T, et al., 2009. Staging/typing of Lewy body related α-synuclein pathology: a study of the BrainNet Europe Consortium. Acta Neuropathol, 117(6):635-652.

[2]Arnold SJ, Dugger BN, Beach TG, 2013. TDP-43 deposition in prospectively followed, cognitively normal elderly individuals: correlation with argyrophilic grains but not other concomitant pathologies. Acta Neuropathol, 126(1):51-57.

[3]Bell WR, An Y, Kageyama Y, et al., 2019. Neuropathologic, genetic, and longitudinal cognitive profiles in primary age-related tauopathy (PART) and Alzheimer’s disease. Alzheimers Dement, 15(1):8-16.

[4]Besser LM, Crary JF, Mock C, et al., 2017. Comparison of symptomatic and asymptomatic persons with primary age-related tauopathy. Neurology, 89(16):1707-1715.

[5]Besser LM, Mock C, Teylan MA, et al., 2019. Differences in cognitive impairment in primary age-related tauopathy versus Alzheimer disease. J Neuropathol Exp Neurol, 78(3):219-228.

[6]Braak H, Thal DR, Ghebremedhin E, et al., 2011. Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol, 70(11):960-969.

[7]Crary JF, Trojanowski JQ, Schneider JA, et al., 2014. Primary age-related tauopathy (PART):a common pathology associated with human aging. Acta Neuropathol, 128(6):755-766.

[8]Duyckaerts C, Braak H, Brion JP, et al., 2015. PART is part of Alzheimer disease. Acta Neuropathol, 129(5):749-756.

[9]Elobeid A, Libard S, Leino M, et al., 2016. Altered proteins in the aging brain. J Neuropathol Exp Neurol, 75(4):316-325.

[10]Jellinger KA, Alafuzoff I, Attems J, et al., 2015. PART, a distinct tauopathy, different from classical sporadic Alzheimer disease. Acta Neuropathol, 129(5):757-762.

[11]Josephs KA, Murray ME, Whitwell JL, et al., 2016. Updated TDP-43 in Alzheimer’s disease staging scheme. Acta Neuropathol, 131(4):571-585.

[12]Josephs KA, Murray ME, Tosakulwong N, et al., 2019. Brain atrophy in primary age-related tauopathy is linked to transactive response DNA-binding protein of 43 kDa. Alzheimers Dement, 15(6):799-806.

[13]Kim D, Kim HS, Choi SM, et al., 2019. Primary age-related tauopathy (PART):an elderly brain pathology frequently encountered during autopsy. J Pathol Transl Med, 53(3):159-163.

[14]Kovacs GG, Milenkovic I, Wöhrer A, et al., 2013. Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series. Acta Neuropathol, 126(3):365-384.

[15]Kuusisto E, Salminen A, Alafuzoff I, 2002. Early accumulation of p62 in neurofibrillary tangles in Alzheimer’s disease: possible role in tangle formation. Neuropathol Appl Neurobiol, 28(3):228-237.

[16]Mikolaenko I, Pletnikova O, Kawas CH, et al., 2005. Alpha-synuclein lesions in normal aging, Parkinson disease, and Alzheimer disease: evidence from the Baltimore Longitudinal Study of Aging (BLSA). J Neuropathol Exp Neurol, 64(2):156-162.

[17]Nelson PT, Trojanowski JQ, Abner EL, et al., 2016. “New old pathologies”: AD, PART, and cerebral age-related TDP-43 with sclerosis (CARTS). J Neuropathol Exp Neurol, 75(6):482-498.

[18]Nelson PT, Dickson DW, Trojanowski JQ, et al., 2019. Limbic-predominant age-related TDP-43 encephalopathy (LATE):consensus working group report. Brain, 142(6):1503-1527.

[19]Tsartsalis S, Xekardaki A, Hof PR, et al., 2018. Early Alzheimer-type lesions in cognitively normal subjects. Neurobiol Aging, 62:34-44.

[20]Uchino A, Takao M, Hatsuta H, et al., 2015. Incidence and extent of TDP-43 accumulation in aging human brain. Acta Neuropathol Commun, 3:35.

[21]Zhang XL, Sun B, Wang X, et al., 2019. Phosphorylated TDP-43 staging of primary age-related tauopathy. Neurosci Bull, 35(2):183-192.

[22]List of electronic supplementary materials

[23]Table S1 Assessment of the altered protein expression